As, in the future, business models within a company can differ between the global, regional and local level, all middle and senior level executives in pharma and medtech companies will benefit from attending this seminar, primarily those in positions that contribute to competitive strategy and organisational development. More specifically, Managers, Directors and Vice-Presidents heading: Business units Country affiliates and regional offices Functional departments, such as Finance, Strategic Planning, Strategic Marketing, Medical Affairs, Market Access, Business Development, R&D, Organisational Development, etc.
By Attending This Course, You Will:
Understand how evolutionary science applies to the life sciences industry.
Discover the 6 fundamental shifts in pharma & medtech’s environment that will determine which business models will thrive and which will fail.
Learn about the fragmentation of the industry landscape into 26 business models.
Know how to identify potential new business models best suited to your company at the global, regional and local levels.
Learn the process to accelerate the evolution of your business models.
Understand the role that your business unit or affiliate can play in the evolution of your company.
Receive Professor Smith’s new book Darwin’s Medicine: How Business Models in the Life Science Industry Are Evolving – which is a complete guide to understanding and directing the evolution of your company.